Tech Company Financing Transactions
Axonics Modulation Technologies Funding Round
Cormorant Asset Management and Gilde Healthcare Partners joined a $20.5 million Series C venture round for Axonics Modulation Technologies. The financing round closed on 7/7/2017.
Transaction Overview
Company Name
Announced On
7/7/2017
Transaction Type
Venture Equity
Amount
$20,500,000
Round
Series C
Investors
Gilde Healthcare Partners (Geoff Pardo)
Proceeds Purpose
Proceeds from the financing will be used to conduct a pivotal clinical study in Overactive Bladder patients to gain U.S. FDA approval and prepare Axonics to access markets around the world.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
26 Technology Dr.
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Not Recorded
Overview
Axonics, based in Irvine, Calif., is a privately held venture-backed pre-revenue company developing novel implantable neuromodulation devices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raymond Cohen
Chief Medical Officer
Karen Noblett
Chief Operating Officer
Daniel Dearen
Chief Technical Officer
Guangqiang Jiang
VP - Bus. Development
Emilie Finiels
VP - General Counsel
Michael Williamson
VP - Marketing
John Woock
VP - Operations
Rinda Sama
VP - Product Management
Prabodh Mathur
Browse more venture capital transactions:
Prev: 7/7/2017: Recycle Track Systems venture capital transaction
Next: 7/7/2017: Insticator venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs